Literature DB >> 4817824

An anthracycline antibiotic-induced cardiomyopathy in rabbits.

R S Jaenke.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4817824

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


× No keyword cloud information.
  32 in total

1.  Inhibition of adriamycin cardiotoxicity by acetyldaunomycin.

Authors:  G Zbinden
Journal:  Experientia       Date:  1975-09-15

Review 2.  Doxorubicin effects on contractile structures and molecules.

Authors:  R Colombo; A Milzani; A Necco; G Vailati
Journal:  Cytotechnology       Date:  1990-01       Impact factor: 2.058

3.  Chemical and morphologic alterations of rabbit bone induced by adriamycin.

Authors:  D M Young; J L Fioravanti; H M Olson; D J Prieur
Journal:  Calcif Tissue Res       Date:  1975-07-04

4.  Ultrastructural features of Adriamycin-induced skeletal and cardiac muscle toxicity.

Authors:  J H Doroshow; C Tallent; J E Schechter
Journal:  Am J Pathol       Date:  1985-02       Impact factor: 4.307

5.  Toxicological evaluation of imipramine in combination with adriamycin and strophanthin.

Authors:  G Zbinden; J Elsner; H Bolliger
Journal:  Agents Actions       Date:  1977-09

6.  Cardiomyopathy in leukemia, with reference to rubidomycin cardiotoxicity.

Authors:  B Lantz; J Adolfsson; B Lagerlöf; P Reizenstein
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

7.  Elevation of serum lipid peroxide level associated with doxorubicin toxicity and its amelioration by [dl]-alpha-tocopheryl acetate or coenzyme Q10 in mouse (doxorubicin, toxicity, lipid peroxide, tocopherol, coenzyme Q10).

Authors:  N Yamanaka; T Kato; K Nishida; T Fujikawa; M Fukushima; K Ota
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

8.  Doxorubicin selectively inhibits muscle gene expression in cardiac muscle cells in vivo and in vitro.

Authors:  H Ito; S C Miller; M E Billingham; H Akimoto; S V Torti; R Wade; R Gahlmann; G Lyons; L Kedes; F M Torti
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

9.  Biological activities of rubidazone.

Authors:  R Maral
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

Review 10.  Myocardial diseases of animals.

Authors:  J F Van Vleet; V J Ferrans
Journal:  Am J Pathol       Date:  1986-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.